Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000544675 | SCV000638231 | pathogenic | Landau-Kleffner syndrome | 2023-03-10 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 464051). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GRIN2A protein function. For these reasons, this variant has been classified as Pathogenic. This missense change has been observed in individual(s) with Landau-Kleffner syndrome (PMID: 29056244). In at least one individual the variant was observed to be de novo. This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 760 of the GRIN2A protein (p.Gly760Ser). This variant is not present in population databases (gnomAD no frequency). |
Institute of Human Genetics, |
RCV000544675 | SCV002026151 | likely pathogenic | Landau-Kleffner syndrome | 2019-01-01 | criteria provided, single submitter | research | |
Gene |
RCV002469190 | SCV002765216 | pathogenic | not provided | 2022-12-13 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27839871, 29896722, 29056244, 34726335) |
Institute of Human Genetics, |
RCV003128410 | SCV003804846 | likely pathogenic | See cases | 2024-08-20 | criteria provided, single submitter | clinical testing | ACMG categories: PM2,PM1,PP3,PP2 |